Friday, December 12, 2025 | 06:37 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India approves Zydus' DNA-based three-dose Covid vaccine for emergency use

Adolescents in the age group of 12-18 years can take the shot in India

ZyCov-D
premium

This 3-dose vaccine which when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, says govt

Agencies
Indigenously developed Zydus Cadila Covid vaccine ZyCoV-D has received approval for Emergency Use Authorisation from the Drug Controller General of India and it will be administered to people 12 years and above, the Department of Biotechnology said on Friday.

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance, it said.

The government's Department of Biotechnology (DBT) also said that the "plug-and-play" technology on which the plasmid DNA